Trial Profile
A Real World study to describe the types of patients prescribed to alirocumab in the United States.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2016
Price :
$35
*
At a glance
- Drugs Alirocumab (Primary)
- Indications Atherosclerosis; Hypercholesterolaemia
- Focus Therapeutic Use
- 21 Dec 2016 New trial record
- 16 Nov 2016 Results (data cut off May 18, 2016; n=564) presented at the 89th Annual Scientific Sessions of the American Heart Association